Viral Shah
Research Subjects
Viral Shah has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chetan Borkhataria
B.K. Mody Government Pharmacy College, Rajkot, India
2 shared publications - Gaurav Sanghvi
Department of Microbiology, Marwadi University, Rajkot, India
2 shared publications - Kiran Dudhat
School of Pharmacy, RK University, Rajkot, India
2 shared publications - Mori Dhaval
B.K. Mody Government Pharmacy College, Rajkot, India
2 shared publications - Sunny Shah
Pharmaceutics, B K Mody Government Pharmacy College, Rajkot, India
2 shared publications - Trupesh Pethani
Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, India
2 shared publications
Latest Publications
- 12 November 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-21
Long-Chained Fatty Acid-Based Solid Dispersions of Voriconazole as an Effective Strategy For Achieving Sustained Release
Voriconazole (VCZ), a second-generation triazole antifungal agent, possesses high oral bioavailability but is associated with substantial pharmaco
- 12 November 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-21
Long-Chained Fatty Acid-Based Solid Dispersions of Voriconazole as an Effective Strategy For Achieving Sustained Release
Voriconazole (VCZ), a second-generation triazole antifungal agent, possesses high oral bioavailability but is associated with substantial pharmaco
- 11 September 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (7) , 1-25
Amorphization of Albendazole Using Organic Acid-based Solid Dispersions for Improved Dissolution: A Solvent-free Approach
Albendazole (ABZ), a broad-spectrum anthelmintic drug, exhibits poor aqueous solubility and low oral bioavailability (< 5%), limiting its ther
- 11 September 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (7) , 1-25
Amorphization of Albendazole Using Organic Acid-based Solid Dispersions for Improved Dissolution: A Solvent-free Approach
Albendazole (ABZ), a broad-spectrum anthelmintic drug, exhibits poor aqueous solubility and low oral bioavailability (< 5%), limiting its ther